Risk Assessment of Diagnostic Categories in the Proposed Sydney System for Reporting Lymph Node Cytopathology: A Retrospective Cytomorphological Study

Document Type : Original Research

Authors

Department of Pathology, All India Institute of Medical Sciences, Patna, Bihar, India

Abstract
Background & Objective: Fine-needle aspiration cytology (FNAC) is a minimally invasive, rapid, and relatively safe diagnostic method for the initial evaluation of lymphadenopathy of unknown origin. In May 2020, the Sydney System was proposed to provide recommendations for diagnostic categorization, FNAC of lymphadenopathy, pathology reporting, and related practices. This study aimed to analyze the applicability of the Sydney System in lymph node FNAC and to evaluate diagnostic accuracy and risk of malignancy (ROM) for each diagnostic category.
Methods: A 2-year retrospective diagnostic study was conducted from January 2019 through December 2020. Sensitivity, specificity, positive predictive value, negative predictive value, diagnostic accuracy (DA), and ROM were calculated using histopathology as the gold standard.
Results: A total of 632 lymph node FNAC cases were included, with histopathological follow-up available in 45 cases. The median age of patients was 26 years, with a male-to-female ratio of 1.2:1. Cervical lymph nodes were most frequently involved (367 cases, 58.1%). Overall sensitivity, specificity, and diagnostic accuracy were 66.7%, 85.0%, and 76.3%, respectively. ROM by diagnostic category was: nondiagnostic (25%), benign (5.2%), atypia of undetermined significance (AUS) (50%), suspicious (80%), and malignant (88.8%).
Conclusion: FNAC demonstrated high diagnostic efficacy when applied using the proposed Sydney System, supporting the utility of this standardized reporting scheme for lymph node cytology.

Keywords

Subjects


Copyright © 2026. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license also allows users to adapt, remix, transform, and build upon the material for any purpose, including commercial use.

1.        Zeppa P. Haematocytopathology: why? Cytopathology. 2012;23(2):73-5. [PMID] [DOI:10.1111/j.1365-2303.2012.00972.x]
2.        Wilkinson AR, Mahore SD, Maimoon SA. FNAC in the diagnosis of lymph node malignancies: A simple and sensitive tool. Indian J Med Paediatr Oncol. 2012;33(01):21-4. [DOI:10.4103/0971-5851.96964] [PMID] [PMCID]
3.        Alam K, Khan A, Siddiqui F, Jain A, Haider N, Maheshwari V. Fine needle aspiration cytology (FNAC), a handy tool for metastatic lymphadenopathy. Int J Pathol. 2010;10(2):1-7. [DOI:10.5580/1df3]
4.        Katz RL. Modern approach to lymphoma diagnosis by fine-needle aspiration. Cancer Cytopathology. 2005;105(6):429-31.      [DOI:10.1002/cncr.21499] [PMID]
5.        Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues: International agency for research on cancer Lyon, France; 2008.
6.        Manzo JL, Cuda J, Pantanowitz L, Xing J, Yu J, Beasley HS, et al. Clinical trial cytology: Use of on-site evaluation of small biopsy and FNA samples for clinical trials and biomarker research studies. Cancer Cytopathol. 2018;126(7). [DOI:10.1002/cncy.22001] [PMID]
7.        Mathiot C, Decaudin D, Klijanienko J, Couturier J, Salomon A, Dumont J, et al. Fine-needle aspiration cytology combined with flow cytometry immunophenotyping is a rapid and accurate approach for the evaluation of suspicious superficial lymphoid lesions. Diagn Cytopathol. 2006;34(7):472-8.    [DOI:10.1002/dc.20487] [PMID]
8.        Al-Abbadi MA, Barroca H, Bode-Lesniewska B, Calaminici M, Caraway NP, Chhieng DF, et al. A Proposal for the Performance, Classification, and Reporting of Lymph Node Fine-Needle Aspiration Cytopathology: The Sydney System. Acta Cytol. 2020;64(4):306-22.      [DOI:10.1159/000506497] [PMID]
9.        Gupta P, Gupta N, Kumar P, Bhardwaj S, Srinivasan R, Dey P, et al. Assessment of risk of malignancy by application of the proposed Sydney system for classification and reporting lymph node cytopathology. Cancer Cytopathol. 2021;129(9):701-18. [DOI:10.1002/cncy.22432] [PMID]
10.     Sundling KE, Kurtycz DFI. Standardized terminology systems in cytopathology. Diagn Cytopathol. 2019;47(1):53-63.  [DOI:10.1002/dc.24103] [PMID]
11.     Pitman MB, Black-Schaffer WS. Post-fine-needle aspiration biopsy communication and the integrated and standardized cytopathology report. Cancer Cytopathol. 2017;125(S6):486-93. [DOI:10.1002/cncy.21821] [PMID]
12.     Vigliar E, Acanfora G, Iaccarino A, Mascolo M, Russo D, Scalia G, et al. A Novel Approach to Classification and Reporting of Lymph Node Fine-Needle Cytology: Application of the Proposed Sydney System. Diagnostics (Basel). 2021;11(8). [PMID] [PMCID] [DOI:10.3390/diagnostics11081314]
13.     Makarenko VV, DeLelys ME, Hasserjian RP, Ly A. Lymph node FNA cytology: Diagnostic performance and clinical implications of proposed diagnostic categories. Cancer Cytopathol. 2022;130(2):144-53.       [DOI:10.1002/cncy.22523] [PMID]
14.     Caputo A, Ciliberti V, D'Antonio A, D'Ardia A, Fumo R, Giudice V, et al. Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology. Cytopathology. 2022;33(2):166-75.             [DOI:10.1111/cyt.13079] [PMID]
15.     Ahuja S, Aziz Khan A, Ahuja R, Ahuja P, Zaheer S. Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the Sydney System for Reporting Lymph Node Fine-Needle Aspiration Biopsy in Diagnosing Malignancy. Acta Cytol. 2024;68(1):13-25. [DOI:10.1159/000535797] [PMID]
16.     Zeppa P, Vigliar E, Cozzolino I, Troncone G, Picardi M, De Renzo A, et al. Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better? Cytopathology. 2010;21(5):300-10. [DOI:10.1111/j.1365-2303.2009.00725.x] [PMID]
17.     Zeppa P, Cozzolino I, Caraway NP, Al-Abbadi MA, Barroca H, Bode-Lesniewska B, et al. Announcement: The International System for Reporting Lymph Node Cytopathology. Acta Cytologica. 2020;64(4):299-305.    [DOI:10.1159/000507413]
Krarup Sigaard R, Wennervaldt K, Munksgaard L, Rahbek Gjerdrum LM, Homoe P. Core needle biopsy is an inferior tool for diagnosing cervical lymphoma compared to lymph node excision. Acta Oncol. 2021;60(7):904-10. [PMID] [DOI:10.1080/0284186X.2021.1916999
Volume 21, Issue 1
Winter 2026
Pages 20-28

  • Receive Date 21 April 2025
  • Revise Date 04 August 2025
  • Accept Date 03 September 2025